Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis. - Wikidata - awgldk - TriplyDB

Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.

Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.

http://www.wikidata.org/entity/Q41075995

about

Continuous control of tracheal cuff pressure for VAP prevention: a collaborative meta-analysis of individual participant data.The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science.Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.Update in Critical Care 2015.Controversies and advances in the management of ventilator associated pneumonia.Ventilator-associated Pneumonia Prevention. Is It Worth It?Airway microbiome research: a modern perspective on surveillance cultures?Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis.Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia.

P2860

Q31027944-0CED26C1-DAA8-479D-A249-634A4991718B Q36295051-F3BF10D4-290C-496A-990E-5768D9ACC067 Q36923519-65D4FD33-9134-40F0-B38A-0ABE0969C0E1 Q37145742-5AB5550F-EFEF-476A-A6FC-644B3344E082 Q37189190-F17A4DC5-3790-4B90-87AF-8DFD3E642697 Q38883355-E5054D5D-3651-45BD-A4E2-D0468D52C994 Q40054170-978A3461-C8BB-4FC7-8DEF-8D44A1199A50 Q46140385-C45B1153-216F-4F26-8021-9BC72F5FA959 Q47101146-A5A63BDA-8CDF-48C5-BA2E-FA3FD7D486FA Q47142541-A77E1A41-CE48-486B-8F69-70FFF7F1A989 Q49920895-A392DBBA-71DC-46D5-85FA-883112D99CCC

P2860

Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.

http://www.wikidata.org/entity/Q41075995

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Determining the Ideal Strategy ...... ention. Cost-Benefit Analysis.

@en

type

label

Determining the Ideal Strategy ...... ention. Cost-Benefit Analysis.

@en

prefLabel

Determining the Ideal Strategy ...... ention. Cost-Benefit Analysis.

@en

P1433

Q41075995-86617B24-937C-4CDF-A3A9-363C8C8C3345

P1476

Q41075995-717DF42F-5358-4FEC-BB1C-8149142D0748

P2093

Q41075995-86A32E09-09D3-4974-ACE6-3DF2797BC641

Q41075995-F3A53958-E8A8-4625-A918-9D2F87334075

P2860

Q41075995-0ACCB5F8-A405-4870-B088-1353204B59F8

Q41075995-0D993EAE-A3B8-4967-AC3A-4E47EA0B4291

Q41075995-16252185-ACFF-4ED4-95AB-6790C6C1EF8C

Q41075995-2198651C-0E83-49D0-A47D-DB6FADE871CD

Q41075995-2EE8B479-6271-4087-9536-474231EB64CA

Q41075995-4101433E-4E3F-46EE-81CC-667C0EC81CCE

Q41075995-41C0D22C-C28C-4A59-9787-29DB6D16D5C8

Q41075995-4442C91E-AFF6-40B3-BC77-782E0FBA3A19

Q41075995-4945E10F-69CD-41B9-9879-A36FEC6C4708

Q41075995-5FEB0088-54B1-4724-9AF1-C6203ED91B9D

P304

Q41075995-1AA89946-B535-42DF-9C15-E06BB88C51FC

P31

Q41075995-213FB0D1-3407-43C5-9B03-A286541EB973

P356

Q41075995-781C09C5-3D3D-4715-AC29-C16563E7EAF5

P407

Q41075995-297D5472-D9C0-4905-8AD2-3F94CA1BB2D6

P433

Q41075995-90A1FCA5-A72E-4CB9-80D5-BE8996320029

P478

Q41075995-06326CD4-1507-4D24-A410-1EC51338EE73

P50

Q41075995-F67969AD-A6C2-466C-86E5-3CAD6D73E49C

P577

Q41075995-DB27EF88-FCBF-4BEB-9D7A-293C7B28A465

P698

Q41075995-13447ABC-4CE7-41E3-877B-0825E9CFBA1F

P921

Q41075995-2BCEEB9E-11AD-4094-AFBD-05E2503BA696

Q41075995-9C68248B-C700-4613-B79F-53725FE21CB5

P356

RCCM.201412-2316OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Determining the Ideal Strategy ...... ention. Cost-Benefit Analysis.

@en

P2093

Michael D Howell

http://www.w3.org/2001/XMLSchema#string

Sharon B Wright

http://www.w3.org/2001/XMLSchema#string

P2860

Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation.

Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.

Raising standards while watching the bottom line: making a business case for infection control.

Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis.

Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU.

Controversies in the management of the critically ill: the role of probiotics.

Oral hygiene regimes for mechanically ventilated patients that use chlorhexidine reduce ventilator-associated pneumonia.

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201412-2316OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P50

Westyn Branch-Elliman

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25871807

http://www.w3.org/2001/XMLSchema#string

P921